Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines

被引：0
|
作者：
Lukas Donix
Holger H. H. Erb
Claudia Peitzsch
Anna Dubrovska
Manuel Pfeifer
Christian Thomas
Susanne Fuessel
Kati Erdmann
机构：
[1] Technische Universität Dresden,Department of Urology, Faculty of Medicine
[2] National Center for Tumor Diseases (NCT),National Center for Radiation Research in Oncology (OncoRay), Faculty of Medicine
[3] Dresden,Helmholtz
[4] Germany: German Cancer Research Center (DKFZ),Zentrum Dresden
[5] Heidelberg,Rossendorf
[6] Germany; Faculty of Medicine and University Hospital Carl Gustav Carus,Institute of Legal Medicine, Faculty of Medicine
[7] Technische Universität Dresden,undefined
[8] Dresden,undefined
[9] Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR),undefined
[10] Technische Universität Dresden,undefined
[11] Institute of Radiooncology - OncoRay,undefined
[12] German Cancer Consortium (DKTK),undefined
[13] Partner Site Dresden,undefined
[14] Dresden and German Cancer Research Center (DKFZ),undefined
[15] Technische Universität Dresden,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
Cisplatin; Docetaxel; mCRPC; NEPC; Prostate cancer; Radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1313 / 1324
页数：11
相关论文
共 50 条
  • [21] X-RAY AND CISPLATIN CROSS-RESISTANCE IN HUMAN-TUMOR CELL-LINES
    SCHWARTZ, JL
    ROTMENSCH, J
    COHEN, M
    WEICHSELBAUM, RR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 341 - 341
  • [22] RBPJ contributes to acquired docetaxel resistance in prostate cancer cells
    Xue, Li
    Wang, Zhenlong
    Li, Hecheng
    Li, Zhaolun
    Chen, Qi
    Zhang, Peng
    Chen, Haiwen
    Wang, Ziming
    Chong, Tie
    MOLECULAR & CELLULAR TOXICOLOGY, 2017, 13 (03) : 279 - 285
  • [23] RBPJ contributes to acquired docetaxel resistance in prostate cancer cells
    Li Xue
    Zhenlong Wang
    Hecheng Li
    Zhaolun Li
    Qi Chen
    Peng Zhang
    Haiwen Chen
    Ziming Wang
    Tie Chong
    Molecular & Cellular Toxicology, 2017, 13 : 279 - 285
  • [24] Cross-Resistance in Small Cell Lung Cancer
    Drapkin, Benjamin
    ONCOLOGIST, 2019, 24 : S3 - S3
  • [25] The Impact of Cross-Resistance Between Paclitaxel and Docetaxel for Metastatic Gastric Cancer
    Shimura, Takaya
    Kitagawa, Mika
    Yamada, Tomonori
    Yoshida, Michihiro
    Ebi, Masahide
    Hirata, Yoshikazu
    Mizushima, Takashi
    Mizoshita, Tsutomu
    Tanida, Satoshi
    Kataoka, Hiromi
    Kamiya, Takeshi
    Joh, Takashi
    ONKOLOGIE, 2012, 35 (04): : 176 - 183
  • [26] CISPLATIN RESISTANCE IN-VITRO IS ACCOMPANIED BY CROSS-RESISTANCE TO SELENITE
    CAFFREY, PB
    FASEB JOURNAL, 1995, 9 (03): : 159 - 159
  • [27] Cross-resistance of dideoxycytidine-resistant cell lines to azidothymidine
    Agarwal, RP
    Wang, W
    Yo, P
    Han, TR
    Fernandez, M
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (10) : 1603 - 1608
  • [28] RESISTANCE (R) AND CROSS-RESISTANCE (XR) OF HUMAN OVARIAN-CANCER (OC) CELL-LINES TO ADRIAMYCIN (AD), MELPHALAN (ME) AND IRRADIATION (XRT)
    BEHRENS, BC
    LOUIE, KG
    HAMILTON, TC
    CURT, G
    KINSELLA, T
    YOUNG, RC
    OZOLS, RF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 336 - 336
  • [29] Characterisation of chromosomal aberrations involved in acquired docetaxel resistance in human breast cancer cell lines
    Turbitt, J.
    Smith, L.
    McAuley, K.
    Massie, D.
    Schofield, A.
    Stevenson, D.
    CHROMOSOME RESEARCH, 2009, 17 : 111 - 112
  • [30] Non-cross resistance of ZD0473 in acquired cisplatin-resistant lung cancer cell lines
    Kawamura-Akiyama, Y
    Kusaba, H
    Kanzawa, F
    Tamura, T
    Saijo, N
    Nishio, K
    LUNG CANCER, 2002, 38 (01) : 43 - 50
12345